2 Pot Stocks to Buy Before Canada’s Cannabis 2.0 Legalization

Canopy Growth Corp (TSX:WEED)(NYSE:CGC) and Hexo Corp (TSX:HEXO)(NYSE:HEXO) are headed for a collision course in the Cannabis 2.0 market. Now is the time to take sides.

| More on:

Canada will legalize cannabis-infused edibles for recreational use this month. The selection of products that will be available in retail outlets, however, will be limited. Nonetheless, the cannabis edibles, extracts, and topical market is estimated to be worth $2.7 billion annually.

Canopy Growth (TSX:WEED)(NYSE:CGC) and Hexo (TSX:HEXO)(NYSE:HEXO) are the pot stocks competing for market leadership in this growth opportunity and have delivered the significant gains to investors.

Potential champion

Canopy continues to disappoint investors so far, and the huge losses recently are worrisome. However, among all cannabis producers, this company has spent the most time and resources toward Cannabis 2.0. Its efforts will soon pay off.

The partnership with alcoholic beverage maker Constellation Brands is a clear sign that Canopy is likely to assume the leadership position in the cannabis-infused beverages market segment. Expect Canopy Growth to introduce multiple cannabis beverages, including zero and low-calorie drinks.

Mark Zekulin, Canopy’s interim CEO, believes that the cannabis beverages market will expand the cannabis consumer category to reach a larger portion of the population. Aside from beverages, Canopy will sell a variety of CBD products, including edibles and oils, later this fiscal year.

Since early July, Canopy has fallen sharply by 41%. But I expect the stock to gain strong momentum when the legal production and sales of cannabis beverages and edibles go into full swing. WEED could rise to $85 or a potential gain of 169%.

Worthy contender

Canopy isn’t the only cannabis producer with a solid financial backer. HEXO is likewise in the best position to be a big winner in the Cannabis 2.0 market. The main objective of forming Truss, a joint venture with beer maker Molson Coors Brewing, is to develop and market cannabis-infused beverages.

That market segment is Hexo’s primary focus. Last June, Hexo CEO Sebastien St.-Louis said that he hasn’t “seen anything else in the industry right now that compares to what we have today” with the first version of its cannabis-infused beverage.

But the company made it known that brisk sales won’t come from cannabis-infused beverages only. HEXO is also developing gummies and premium vape products. St.-Louis believes that these two could be the top-selling products that could match beverages in terms of market opportunity.

The competitive advantage of Hexo is its dominance in the province of Quebec. Currently, HEXO holds a leading market share of 30% in the province that ranks second to Ontario in terms of population size.

Hexo is down 19.0% since early June, but because of its enormous growth potential in the Cannabis 2.0 market, analysts are forecasting a 152% potential upside in the next 12 months.

Collision course

Expect a few kinks before the beverages and edibles markets get going. Health Canada is the process of crafting a strict legal framework that would ensure public safety. The cannabis sector is on the verge of creating valuable new growth opportunities with cannabis edibles and other alternative products.

But the winner in the Cannabis 2.0 market is a toss-up between team Canopy-Constellation and team Hexo-Molson Coors. It’s is going to be an exciting head-to-head battle. Pick your pot stock now, and may the better side win.

Fool contributor Christopher Liew has no position in any of the stocks mentioned. The Motley Fool owns shares of Molson Coors Brewing.

More on Cannabis Stocks

Farmer smiles near cannabis crop
Cannabis Stocks

TFSA Investors: An Undervalued Cannabis Stock You Can Buy for $500 Right Now

Down almost 70% from all-time highs, Curaleaf is a TSX cannabis stock that trades at an attractive valuation in December…

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Can Canopy Growth Stock Finally Recover in 2026, as Donald Trump Might Ease Cannabis Restrictions?

Down over 99% from all-time highs, Canopy Growth stock might recover in 2026 if the Trump administration reclassifies cannabis products.

Read more »

Researcher works in hemp field
Cannabis Stocks

Forget Tilray and Buy This Cannabis Stock if the U.S. Reclassifies Marijuana in 2026

While Tilray stock gained over 40% on Friday, this cannabis company is a better buy if the U.S. reclassifies marijuana…

Read more »

A cannabis plant grows.
Cannabis Stocks

Aurora Cannabis Surged 21% on Possible Cannabis Reclassification in the U.S. Is ACB Stock Finally a Good Buy?

Down almost 99% from all-time highs, Aurora Cannabis is a beaten-down marijuana stock that offers upside potential in December 2025.

Read more »

four people hold happy emoji masks
Dividend Stocks

Wary of Mining Companies? A Lower-Risk Way to Get in on the Gold and Silver Surge

Frenco-Nevada (TSX:FNV) stock might be a wiser way to play the run in gold prices this year.

Read more »

Cannabis smoke
Cannabis Stocks

Have Cannabis Stocks Totally Gone Up in Smoke?

Let's dive into whether Canadian cannabis stocks are still investable, and what investors should make of the recent volatility in…

Read more »

Researcher works in hemp field
Cannabis Stocks

1 Undervalued Cannabis Stock to Buy and Hold Over the Next Decade

Green Thumb is a beaten-down cannabis stock that trades at a compelling valuation in September 2025.

Read more »

Researcher works in hemp field
Cannabis Stocks

Pot Stocks Rallied Hard in August: Is There More to Come?

Tilray Brands (TSX:TLRY) and the broad basket of pot stocks could heat up from here.

Read more »